Fransen Floris, Heckenberg Sebastiaan G B, Hamstra Hendrik Jan, Feller Moniek, Boog Claire J P, van Putten Jos P M, van de Beek Diederik, van der Ende Arie, van der Ley Peter
Laboratory of Vaccine Research, Netherlands Vaccine Institute, Bilthoven, The Netherlands.
PLoS Pathog. 2009 Apr;5(4):e1000396. doi: 10.1371/journal.ppat.1000396. Epub 2009 Apr 24.
Neisseria meningitidis is a major cause of bacterial meningitis and sepsis worldwide. Lipopolysaccharide (LPS), a major component of the Gram-negative bacterial outer membrane, is sensed by mammalian cells through Toll-like receptor 4 (TLR4), resulting in activation of proinflammatory cytokine pathways. TLR4 recognizes the lipid A moiety of the LPS molecule, and the chemical composition of the lipid A determines how well it is recognized by TLR4. N. meningitidis has been reported to produce lipid A with six acyl chains, the optimal number for TLR4 recognition. Indeed, meningococcal sepsis is generally seen as the prototypical endotoxin-mediated disease. In the present study, we screened meningococcal disease isolates from 464 patients for their ability to induce cytokine production in vitro. We found that around 9% of them were dramatically less potent than wild-type strains. Analysis of the lipid A of several of the low-activity strains by mass spectrometry revealed they were penta-acylated, suggesting a mutation in the lpxL1 or lpxL2 genes required for addition of secondary acyl chains. Sequencing of these genes showed that all the low activity strains had mutations that inactivated the lpxL1 gene. In order to see whether lpxL1 mutants might give a different clinical picture, we investigated the clinical correlate of these mutations in a prospective nationwide observational cohort study of adults with meningococcal meningitis. Patients infected with an lpxL1 mutant presented significantly less frequently with rash and had higher thrombocyte counts, consistent with reduced cytokine induction and less activation of tissue-factor mediated coagulopathy. In conclusion, here we report for the first time that a surprisingly large fraction of meningococcal clinical isolates have LPS with underacylated lipid A due to mutations in the lpxL1 gene. The resulting low-activity LPS may have an important role in virulence by aiding the bacteria to evade the innate immune system. Our results provide the first example of a specific mutation in N. meningitidis that can be correlated with the clinical course of meningococcal disease.
脑膜炎奈瑟菌是全球细菌性脑膜炎和败血症的主要病因。脂多糖(LPS)是革兰氏阴性菌外膜的主要成分,哺乳动物细胞通过Toll样受体4(TLR4)感知LPS,从而激活促炎细胞因子途径。TLR4识别LPS分子的脂质A部分,脂质A的化学组成决定了它被TLR4识别的程度。据报道,脑膜炎奈瑟菌产生的脂质A有六条酰基链,这是TLR4识别的最佳数量。事实上,脑膜炎球菌败血症通常被视为典型的内毒素介导疾病。在本研究中,我们筛选了464例患者的脑膜炎球菌病分离株在体外诱导细胞因子产生的能力。我们发现其中约9%的分离株的效力远低于野生型菌株。通过质谱分析几种低活性菌株的脂质A,发现它们是五酰化的,这表明在添加二级酰基链所需的lpxL1或lpxL2基因中存在突变。对这些基因进行测序表明,所有低活性菌株都有使lpxL1基因失活的突变。为了观察lpxL1突变体是否可能呈现不同的临床症状,我们在一项针对患有脑膜炎球菌性脑膜炎的成年人的全国性前瞻性观察队列研究中,调查了这些突变与临床的相关性。感染lpxL1突变体的患者出现皮疹的频率明显较低,血小板计数较高,这与细胞因子诱导减少和组织因子介导的凝血病变激活较少一致。总之,我们首次报告,由于lpxL1基因发生突变,相当大比例的脑膜炎球菌临床分离株的LPS具有酰基化不足的脂质A。由此产生的低活性LPS可能通过帮助细菌逃避先天免疫系统而在毒力方面发挥重要作用。我们的结果提供了脑膜炎奈瑟菌中一个特定突变的首个实例,该突变可与脑膜炎球菌病的临床病程相关。